Has Cato Laurencin received payments from drug or device companies?

Yes. Drug and device makers reported $3,483,474 in general payments to Cato Laurencin across 321 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cato Laurencin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cato Laurencin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cato Laurencin

Orthopaedic Surgery · Charlottesville, VANPI 1417026048

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,801,792 of the $3,483,474 with a category attached, or 80.4%. Alkermes, Inc. accounts for 77.9% of it on its own, with 9 other manufacturers making up the rest. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,483,474in general payments, 2019–2025

Across 321 payments — averaging $10,852 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$2.7M
Mimedx Group, Inc.$548K
Endo Pharmaceuticals Inc.$105K
Linvatec Corporation$66K
Janssen Global Services, LLC$31K
Bioventus LLC$14K
plus $5K from 4 others

$159,087in research payments, 2019–2025

Across 19 payments — averaging $8372.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Endo Pharmaceuticals Inc.$159K

What the payments were for

Consulting fees$2,801,79280%
Speaking & faculty fees$494,82614%
Travel & lodging$112,2103%
Food & beverage$8,4010%
Education$1660%
Other$66,0782%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	245	$2,715,112
Mimedx Group, Inc.	36	$547,713
Endo Pharmaceuticals Inc.	20	$105,016
Linvatec Corporation	9	$66,078
Janssen Global Services, LLC	5	$31,199
Bioventus LLC	2	$13,750
Medical Device Business Services, Inc.	1	$4,150
Stryker	1	$161
Arthrex	1	$154
Depuy Synthes Products, Inc.	1	$142

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,483,474 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia →

Other orthopaedic surgery in Charlottesville

William MihalkoCharlottesville$2M
Stephen GuntherCharlottesville$545K
Adam ShimerCharlottesville$303K
Charles SuCharlottesville$47K
Dale YoungNorth Chesterfield$10.9M
James DowdVirginia Beach$6.1M
Mark de BloisNorth Chesterfield$4M
Randall PeytonSterling$2.9M
David MillerNorth Chesterfield$1.7M
Keith LawhornFairfax$1.6M

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →